Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3.

The American journal of gastroenterology - 1 Apr 2007

Shiffman Mitchell L, Mihas Anastasios A, Millwala Farida, Sterling Richard K, Luketic Velimir A, Stravitz R Todd, Sanyal Arun J

Abstract excerpt

Previous studies have documented that sustained virologic response (SVR) is significantly reduced in African Americans with chronic HCV genotype 1 following treatment with interferon and ribavirin when compared with Caucasians. The specific aim of the present retrospective study was to assess virologic response to interferon and ribavirin in African Americans with HCV genotypes 2 and 3. A review of our database...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Hepatitis C, Chronic

Share to Interferons

Share to Liver Function Tests

Share to Ribavirin

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 17319933
DOI: 10.1111/j.1572-0241.2007.01092.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3.PMID 17319933Read ↗

Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.Semantic proximity Read ↗

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.Semantic proximity Read ↗

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.Semantic proximity Read ↗

Hepatitis C virus infection in African Americans.Semantic proximity Read ↗

Equally poor outcomes to pegylated interferon-based therapy in African Americans and Hispanics with chronic hepatitis C infection.Semantic proximity Read ↗

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.Semantic proximity Read ↗

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.Semantic proximity Read ↗

Hepatitis C treatment outcomes of African Americans following liver transplantation.Semantic proximity Read ↗

Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients.Semantic proximity Read ↗

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.Semantic proximity Read ↗

Factors influencing treatment outcome in hepatitis C virus minority patients at an inner-city hospital: A STROBE-complaint article.Semantic proximity Read ↗

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.